Skip to content

Clinical trials

Phase 2 Reperfusion Injury trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Reperfusion Injury Phase: Phase 2 Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20053
20071
20083
20092
20122
20131
20143
20154
20171
20181
20201
20212
20224
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting5
Unknown status4
Terminated2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dompé Farmaceutici S.p.A3
Westat2
Alavita Pharmaceuticals Inc1
Amosov National Institute of Cardiovascular Surgery1
Asan Medical Center1
Barts & The London NHS Trust1
Bilix Co.,Ltd.1
Erasme University Hospital1
Herlev Hospital1
Hospices Civils de Lyon1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Reperfusion Injury35
Acute Kidney Injury6
Myocardial Infarction6
ST Elevation Myocardial Infarction6
Myocardial Ischemia4
Hemorrhage2
Myocardial Reperfusion Injury2
Acute Coronary Syndrome1
Angina Pectoris1
Aortic Valve Stenosis1

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.